Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE9.8300
- TODAY'S CHANGE (%)0.6300 (6.8478%)
- Bid / Lots9.7000/ 1
- Ask / Lots10.0000/ 2
- Open / Previous Close9.2300 / 9.2000
- Day Range
- 52 Week Range
- Volume11,569,251
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 1210 | 9.23 |
| 09:34 ET | 455 | 9.135 |
| 09:36 ET | 100 | 9.22 |
| 09:39 ET | 100 | 9.22 |
| 09:41 ET | 3804 | 9.33 |
| 09:43 ET | 300 | 9.33 |
| 09:45 ET | 400 | 9.275 |
| 09:48 ET | 2927 | 9.31 |
| 09:50 ET | 850 | 9.31 |
| 09:52 ET | 2598 | 9.4266 |
| 09:54 ET | 500 | 9.44 |
| 09:56 ET | 3570 | 9.465 |
| 09:57 ET | 400 | 9.455 |
| 09:59 ET | 300 | 9.48 |
| 10:01 ET | 3936 | 9.36 |
| 10:03 ET | 5215 | 9.37 |
| 10:06 ET | 2232 | 9.405 |
| 10:08 ET | 229 | 9.4 |
| 10:10 ET | 1725 | 9.42 |
| 10:12 ET | 400 | 9.43 |
| 10:14 ET | 19316 | 9.39 |
| 10:15 ET | 400 | 9.4 |
| 10:17 ET | 1435 | 9.4 |
| 10:19 ET | 300 | 9.45 |
| 10:21 ET | 2961 | 9.46 |
| 10:24 ET | 793 | 9.4334 |
| 10:26 ET | 2900 | 9.4201 |
| 10:28 ET | 715 | 9.45 |
| 10:30 ET | 7399 | 9.45 |
| 10:32 ET | 2150 | 9.47 |
| 10:35 ET | 3170 | 9.4 |
| 10:37 ET | 3809 | 9.37 |
| 10:39 ET | 3294 | 9.41 |
| 10:42 ET | 800 | 9.415 |
| 10:44 ET | 5750 | 9.4 |
| 10:46 ET | 510 | 9.4 |
| 10:48 ET | 5028 | 9.38 |
| 10:50 ET | 2555 | 9.35 |
| 10:51 ET | 1129 | 9.36 |
| 10:53 ET | 2247 | 9.355 |
| 10:55 ET | 2978 | 9.35 |
| 10:57 ET | 3004 | 9.36 |
| 11:00 ET | 3035 | 9.37 |
| 11:02 ET | 5200 | 9.29 |
| 11:04 ET | 879 | 9.31 |
| 11:06 ET | 1448 | 9.31 |
| 11:08 ET | 3000 | 9.37 |
| 11:09 ET | 2019 | 9.41 |
| 11:11 ET | 100 | 9.43 |
| 11:13 ET | 484 | 9.405 |
| 11:15 ET | 5081 | 9.365 |
| 11:18 ET | 2835 | 9.33 |
| 11:20 ET | 1300 | 9.33 |
| 11:22 ET | 3834 | 9.35 |
| 11:24 ET | 400 | 9.34 |
| 11:26 ET | 616 | 9.37 |
| 11:27 ET | 6370 | 9.37 |
| 11:29 ET | 5293 | 9.3685 |
| 11:31 ET | 3092 | 9.35 |
| 11:33 ET | 587 | 9.35 |
| 11:36 ET | 893 | 9.35 |
| 11:38 ET | 9965 | 9.37 |
| 11:40 ET | 2606 | 9.37 |
| 11:42 ET | 500 | 9.39 |
| 11:44 ET | 717 | 9.38 |
| 11:45 ET | 2366 | 9.37 |
| 11:47 ET | 200 | 9.38 |
| 11:49 ET | 3975 | 9.3616 |
| 11:51 ET | 1248 | 9.38 |
| 11:54 ET | 1074 | 9.38 |
| 11:58 ET | 2502 | 9.4 |
| 12:00 ET | 1893 | 9.405 |
| 12:02 ET | 3306 | 9.46 |
| 12:03 ET | 300 | 9.46 |
| 12:05 ET | 2755 | 9.44 |
| 12:07 ET | 689 | 9.43 |
| 12:09 ET | 2148 | 9.401 |
| 12:12 ET | 1829 | 9.41 |
| 12:14 ET | 814 | 9.41 |
| 12:16 ET | 1755 | 9.41 |
| 12:18 ET | 300 | 9.41 |
| 12:20 ET | 5909 | 9.43 |
| 12:21 ET | 300 | 9.43 |
| 12:23 ET | 2187 | 9.45 |
| 12:25 ET | 3173 | 9.47 |
| 12:27 ET | 1729 | 9.49 |
| 12:30 ET | 950 | 9.55 |
| 12:32 ET | 4905 | 9.6 |
| 12:34 ET | 5828 | 9.58 |
| 12:36 ET | 8413 | 9.54 |
| 12:38 ET | 2400 | 9.54 |
| 12:39 ET | 2590 | 9.51 |
| 12:41 ET | 1757 | 9.51 |
| 12:43 ET | 4103 | 9.48 |
| 12:45 ET | 2709 | 9.51 |
| 12:48 ET | 6333 | 9.55 |
| 12:50 ET | 1100 | 9.55 |
| 12:52 ET | 5652 | 9.555 |
| 12:54 ET | 1161 | 9.56 |
| 12:56 ET | 6755 | 9.57 |
| 12:57 ET | 4494 | 9.54 |
| 12:59 ET | 597 | 9.53 |
| 01:01 ET | 4837 | 9.48 |
| 01:03 ET | 12179 | 9.555 |
| 01:06 ET | 5294 | 9.58 |
| 01:08 ET | 1528 | 9.61 |
| 01:10 ET | 2347 | 9.61 |
| 01:12 ET | 8740 | 9.57 |
| 01:14 ET | 472 | 9.57 |
| 01:15 ET | 1536 | 9.58 |
| 01:17 ET | 641 | 9.59 |
| 01:19 ET | 4922 | 9.62 |
| 01:21 ET | 16965 | 9.48 |
| 01:24 ET | 841 | 9.48 |
| 01:26 ET | 2981 | 9.505 |
| 01:28 ET | 3256 | 9.505 |
| 01:30 ET | 6770 | 9.53 |
| 01:32 ET | 433 | 9.53 |
| 01:33 ET | 1986 | 9.52 |
| 01:35 ET | 8663 | 9.5 |
| 01:37 ET | 6096 | 9.48 |
| 01:39 ET | 4470 | 9.46 |
| 01:42 ET | 2470 | 9.44 |
| 01:44 ET | 4564 | 9.46 |
| 01:46 ET | 1134 | 9.47 |
| 01:48 ET | 1863 | 9.49 |
| 01:50 ET | 3964 | 9.49 |
| 01:51 ET | 3405 | 9.5 |
| 01:53 ET | 20195 | 9.575 |
| 01:55 ET | 2346 | 9.55 |
| 01:57 ET | 7651 | 9.54 |
| 02:00 ET | 3140 | 9.53 |
| 02:02 ET | 1914 | 9.565 |
| 02:04 ET | 4070 | 9.61 |
| 02:06 ET | 7024 | 9.53 |
| 02:08 ET | 17651 | 9.5 |
| 02:09 ET | 9613 | 9.57 |
| 02:11 ET | 3953 | 9.53 |
| 02:13 ET | 2334 | 9.515 |
| 02:15 ET | 14232 | 9.525 |
| 02:18 ET | 4183 | 9.52 |
| 02:20 ET | 1026 | 9.52 |
| 02:22 ET | 3236 | 9.51 |
| 02:24 ET | 6418 | 9.49 |
| 02:26 ET | 1453 | 9.5 |
| 02:27 ET | 900 | 9.5 |
| 02:29 ET | 9364 | 9.52 |
| 02:31 ET | 3358 | 9.49 |
| 02:33 ET | 1600 | 9.49 |
| 02:36 ET | 1780 | 9.5 |
| 02:38 ET | 3302 | 9.505 |
| 02:40 ET | 1500 | 9.51 |
| 02:42 ET | 3624 | 9.49 |
| 02:44 ET | 3886 | 9.51 |
| 02:45 ET | 2496 | 9.505 |
| 02:47 ET | 3547 | 9.515 |
| 02:49 ET | 2349 | 9.53 |
| 02:51 ET | 6113 | 9.5 |
| 02:54 ET | 3949 | 9.45 |
| 02:56 ET | 6333 | 9.49 |
| 02:58 ET | 3278 | 9.5 |
| 03:00 ET | 5615 | 9.48 |
| 03:02 ET | 5692 | 9.47 |
| 03:03 ET | 4248 | 9.471 |
| 03:05 ET | 10335 | 9.47 |
| 03:07 ET | 21945 | 9.51 |
| 03:09 ET | 6113 | 9.495 |
| 03:12 ET | 14431 | 9.51 |
| 03:14 ET | 12520 | 9.515 |
| 03:16 ET | 18636 | 9.55 |
| 03:18 ET | 8912 | 9.56 |
| 03:20 ET | 8240 | 9.55 |
| 03:21 ET | 6952 | 9.55 |
| 03:23 ET | 10141 | 9.57 |
| 03:25 ET | 5129 | 9.58 |
| 03:27 ET | 21115 | 9.61 |
| 03:30 ET | 14938 | 9.63 |
| 03:32 ET | 8935 | 9.605 |
| 03:34 ET | 2213 | 9.61 |
| 03:36 ET | 14491 | 9.68 |
| 03:38 ET | 21123 | 9.675 |
| 03:39 ET | 7094 | 9.67 |
| 03:41 ET | 17265 | 9.62 |
| 03:43 ET | 3746 | 9.65 |
| 03:45 ET | 19841 | 9.61 |
| 03:48 ET | 3925 | 9.67 |
| 03:50 ET | 21213 | 9.67 |
| 03:52 ET | 186062 | 9.82 |
| 03:54 ET | 67776 | 9.87 |
| 03:56 ET | 125130 | 9.82 |
| 03:57 ET | 47925 | 9.81 |
| 03:59 ET | 56184 | 9.83 |
Jun 20, 2024
Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer's Disease Agitation, from 7:00AM ET on Thursday Jun 20, 2024 by Dow Jones
7:00AM ET on Thursday Jun 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 1.4B | -6.4x | --- |
Soleno Therapeutics Inc | 1.4B | -15.2x | --- |
Belite Bio Inc | 1.5B | -38.8x | --- |
Disc Medicine Inc | 1.3B | -13.4x | --- |
Verona Pharma PLC | 1.2B | -18.3x | --- |
Spyre Therapeutics Inc | 1.2B | -0.3x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Strategy Officer
- Daljit Aurora
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 159.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.55 |
Book Value | $2.95 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
